Erin K. Willert

442 total citations
30 papers, 361 citations indexed

About

Erin K. Willert is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Erin K. Willert has authored 30 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Radiology, Nuclear Medicine and Imaging, 13 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Erin K. Willert's work include Monoclonal and Polyclonal Antibodies Research (17 papers), Toxin Mechanisms and Immunotoxins (9 papers) and Synthesis and Biological Evaluation (8 papers). Erin K. Willert is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (17 papers), Toxin Mechanisms and Immunotoxins (9 papers) and Synthesis and Biological Evaluation (8 papers). Erin K. Willert collaborates with scholars based in United States, Switzerland and Netherlands. Erin K. Willert's co-authors include Margaret A. Phillips, Richard Fitzpatrick, Herbert W. Virgin, L. Steven Johnson, Jack P. Higgins, Hanlan Liu, Yibin Xiang, Robert H. Barker, Edmund J. Sybertz and Bradford Hirth and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Erin K. Willert

30 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erin K. Willert United States 11 230 175 67 65 63 30 361
Surya P. Manandhar United States 12 213 0.9× 33 0.2× 44 0.7× 9 0.1× 64 1.0× 22 400
Maria Ekblad Sweden 12 147 0.6× 147 0.8× 37 0.6× 11 0.2× 16 0.3× 15 368
Melvin Au Singapore 7 277 1.2× 113 0.6× 49 0.7× 51 0.8× 9 0.1× 8 422
Thalita Bachelli Riul Brazil 12 159 0.7× 42 0.2× 25 0.4× 19 0.3× 44 0.7× 16 365
Pu Chen China 9 140 0.6× 57 0.3× 20 0.3× 16 0.2× 11 0.2× 21 310
Anaïs Merckx France 8 121 0.5× 158 0.9× 38 0.6× 19 0.3× 241 3.8× 15 436
Arja Kallio Finland 11 243 1.1× 82 0.5× 24 0.4× 21 0.3× 14 0.2× 16 366
Paul Depledge United Kingdom 9 134 0.6× 23 0.1× 86 1.3× 34 0.5× 57 0.9× 12 326
You Yu China 12 358 1.6× 78 0.4× 60 0.9× 7 0.1× 44 0.7× 21 578
Mathieu S. Chevalier United States 8 171 0.7× 98 0.6× 35 0.5× 15 0.2× 9 0.1× 10 338

Countries citing papers authored by Erin K. Willert

Since Specialization
Citations

This map shows the geographic impact of Erin K. Willert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin K. Willert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin K. Willert more than expected).

Fields of papers citing papers by Erin K. Willert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin K. Willert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin K. Willert. The network helps show where Erin K. Willert may publish in the future.

Co-authorship network of co-authors of Erin K. Willert

This figure shows the co-authorship network connecting the top 25 collaborators of Erin K. Willert. A scholar is included among the top collaborators of Erin K. Willert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin K. Willert. Erin K. Willert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ramos, Hilario J., et al.. (2020). Abstract 539: Novel engineered toxin bodies targeting SLAMF7 (CS1). Cancer Research. 80(16_Supplement). 539–539. 1 indexed citations
2.
Waltzman, Roger J., et al.. (2020). MT-5111: A novel HER2 targeting engineered toxin body in clinical development.. Journal of Clinical Oncology. 38(4_suppl). 433–433. 8 indexed citations
3.
Higgins, Jack P., Erin K. Willert, John Newcomb, et al.. (2020). TAK-169, a Novel Recombinant Immunotoxin Specific for CD38, Induces Powerful Preclinical Activity Against Patient-Derived Multiple Myeloma Cells. Blood. 136(Supplement 1). 11–12. 12 indexed citations
4.
Willert, Erin K., Jack P. Higgins, Janice Lee, et al.. (2019). Abstract 2384: TAK-169, an exceptionally potent CD38 targeted engineered toxin body, as a novel direct cell kill approach for the treatment of multiple myeloma. Cancer Research. 79(13_Supplement). 2384–2384. 14 indexed citations
5.
6.
7.
Higgins, Jack P., et al.. (2019). Abstract 2060: Combination of CD20 targeted engineered toxin body, MT-3724, with chemotherapy or IMiDs for the treatment of non Hodgkin's lymphoma. Cancer Research. 79(13_Supplement). 2060–2060. 2 indexed citations
8.
Neill, Jane, et al.. (2016). Abstract 595: Next-generation engineered toxin bodies: CD38, PD-L1 and HER2 targeted ETBs. Cancer Research. 76(14_Supplement). 595–595. 2 indexed citations
9.
Neill, Jane, et al.. (2016). Abstract 1483: MT-3724, an engineered toxin body targeting CD20 for non-Hodgkin's lymphoma. Cancer Research. 76(14_Supplement). 1483–1483. 1 indexed citations
10.
Willert, Erin K., et al.. (2015). Abstract P4-15-17: A novel targeted engineered toxin body for treatment of HER2 positive breast cancer. Cancer Research. 75(9_Supplement). P4–15. 2 indexed citations
11.
Willert, Erin K., et al.. (2013). CD20-Specific Engineered Toxin Body Demonstrates Direct Cell Kill Of Multiple B-Cell Non-Hodgkin's Lymphoma Types. Blood. 122(21). 5152–5152. 1 indexed citations
12.
Willert, Erin K., et al.. (2013). Abstract 5477: Engineered toxin body demonstrating CD20-specific binding and cell kill in B-cell non-Hodgkin's lymphoma cells.. Cancer Research. 73(8_Supplement). 5477–5477. 1 indexed citations
13.
Willert, Erin K. & Margaret A. Phillips. (2011). Regulation and function of polyamines in African trypanosomes. Trends in Parasitology. 28(2). 66–72. 33 indexed citations
14.
Willert, Erin K., Lisa N. Kinch, & Margaret A. Phillips. (2011). Identification and Assay of Allosteric Regulators of S-Adenosylmethionine Decarboxylase. Methods in molecular biology. 720. 219–235. 1 indexed citations
15.
Johnson, L. Steven, Erin K. Willert, & Herbert W. Virgin. (2010). Redefining the Genetics of Murine Gammaherpesvirus 68 via Transcriptome-Based Annotation. Cell Host & Microbe. 7(6). 516–526. 26 indexed citations
16.
Willert, Erin K. & Margaret A. Phillips. (2009). Cross-species activation of trypanosome S-adenosylmethionine decarboxylase by the regulatory subunit prozyme. Molecular and Biochemical Parasitology. 168(1). 1–6. 20 indexed citations
17.
Hirth, Bradford, Robert H. Barker, Cassandra A. Celatka, et al.. (2009). Discovery of new S-adenosylmethionine decarboxylase inhibitors for the treatment of Human African Trypanosomiasis (HAT). Bioorganic & Medicinal Chemistry Letters. 19(11). 2916–2919. 16 indexed citations
18.
Barker, Robert H., Hanlan Liu, Bradford Hirth, et al.. (2009). NovelS-Adenosylmethionine Decarboxylase Inhibitors for the Treatment of Human African Trypanosomiasis. Antimicrobial Agents and Chemotherapy. 53(5). 2052–2058. 31 indexed citations
19.
Willert, Erin K. & Margaret A. Phillips. (2008). Regulated Expression of an Essential Allosteric Activator of Polyamine Biosynthesis in African Trypanosomes. PLoS Pathogens. 4(10). e1000183–e1000183. 52 indexed citations
20.
Willert, Erin K., Richard Fitzpatrick, & Margaret A. Phillips. (2007). Allosteric regulation of an essential trypanosome polyamine biosynthetic enzyme by a catalytically dead homolog. Proceedings of the National Academy of Sciences. 104(20). 8275–8280. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Surya P. Manandhar Breakdown of academic impact, for papers by Maria Ekblad Breakdown of academic impact, for papers by Melvin Au Breakdown of academic impact, for papers by Thalita Bachelli Riul Breakdown of academic impact, for papers by Pu Chen Breakdown of academic impact, for papers by Anaïs Merckx Breakdown of academic impact, for papers by Arja Kallio Breakdown of academic impact, for papers by Paul Depledge Breakdown of academic impact, for papers by You Yu Breakdown of academic impact, for papers by Mathieu S. Chevalier
Rankless by CCL
2026